Simplified Chinese
Good News | Minhai Bio Honored with the 2025 Beijing “Low-Carbon Leader” Title
Release date:
2026-01-05
Author:
Source:
Abstract
Recently, the Beijing Municipal Ecology and Environment Bureau officially released the 2025 list of “Beijing Low-Carbon Leaders,” which includes a total of six companies. Beijing Minhai Biotechnology Co., Ltd. (hereinafter referred to as “Minhai Bio”) was successfully selected for the list, thanks to its outstanding achievements in green manufacturing and energy conservation and carbon reduction, becoming the only enterprise in Daxing District to receive this honor this year. This recognition marks another significant milestone for Minhai Bio on its sustainable development journey, following its earlier designation as a “National-Level Green Factory,” and further reinforces its leading position as a benchmark for low-carbon development in the biopharmaceutical industry.
Systematic Decarbonization: Green Practices Across the Entire Value Chain, from R&D to Production and Operations
Minhai Biotechnology has made its “New‑Generation Vaccine Internationalization Industrial Base” in Daxing District the cornerstone of its green transformation, creating a garden‑style factory that seamlessly integrates cutting‑edge biotechnology with eco‑friendly design. Guided by the design philosophy of “harmonious coexistence between humanity and nature,” the campus maximizes natural lighting, optimizes ventilation systems, and cultivates multi‑layered vegetation landscapes, achieving an organic integration of the production environment and the surrounding ecological setting.
In the realm of energy and resource management, the company leverages an intelligent energy‑control platform to conduct real-time monitoring and dynamic optimization of key energy‑consumption units, including water, electricity, and gas. By harnessing IoT and big‑data analytics, it has achieved a substantial overall improvement in energy efficiency. Meanwhile, the enterprise has independently developed a rainwater‑harvesting system and a reclaimed‑water reuse system, utilizing recovered water for park landscaping irrigation and landscape maintenance, thereby significantly reducing its reliance on municipal water supplies.
To deepen the transformation of its energy mix, Minhai Bio has launched a systematic green‑energy initiative since 2023. On the one hand, the company proactively procures green electricity to optimize its energy consumption profile; on the other, it actively promotes self‑consumption of renewable energy by deploying solar water‑heating systems across its residential areas, bringing clean energy directly into employees’ daily lives. By simultaneously integrating clean energy into both production and everyday settings, the company has begun to establish a closed-loop framework for low‑carbon development that aligns operations with community sustainability.
Authoritative Recognition: Awarded national-level green certification, continuously strengthening the low-carbon management system.
As an industry-leading “National-Level Green Factory,” Minhai Biologics has been recognized for four consecutive years as a “Five-Star Green Credit Enterprise” by Daxing District. The company has comprehensively established and implemented ISO 50001 (Energy Management System), ISO 14001 (Environmental Management System), ISO 45001 (Occupational Health and Safety Management System), and ISO 9001 (Quality Management System), achieving integrated synergy across environmental, energy, safety, and quality management. Its vaccine production base embeds low-carbon principles from the very outset of process design, rigorously adheres to green standards throughout all stages—including raw material procurement, manufacturing processes, and waste disposal—and has set clear targets for increasing the use of green electricity, along with a detailed roadmap for achieving “zero carbon” operations at the facility.
Future Outlook: Deepening Zero-Carbon Initiatives and Co‑Building a Green Industrial Chain
“Being recognized as a ‘Low‑Carbon Leader’ is not only an acknowledgment of our past green initiatives but also a significant responsibility,” said a representative from Minhai Biologics. Looking ahead, the company will further increase its share of renewable energy use, steadily advance the development of a “zero‑carbon factory,” and continuously reduce its carbon intensity through technological innovation and operational optimization. At the same time, Minhai Biologics will actively collaborate with upstream and downstream partners across the value chain to jointly explore and establish a full‑life‑cycle low‑carbon management model spanning vaccine R&D, production, logistics, and vaccination, striving to contribute a more impactful industrial force toward achieving Beijing’s—and the nation’s—dual carbon goals.
Keywords:
Recommended Reading
Batch Release Status of the Company’s Products in 2026
2026-07-23
2026-07-15
2026-07-09
Contact Information
Customer Service Hotline
4001899806
Phone number
010-59613600
Official Website
Company Address
No. 35 Simiao Road and No. 25 Tianfu Street, Daxing Biomedical Industry Base, Zhongguancun Science Park, Daxing District, Beijing
WeChat Official Account